Biogen Idec, Inc., Drug Discovery Department, 12 Cambridge Center, Cambridge, Massachusetts 02142, USA.
Protein Sci. 2010 Mar;19(3):429-39. doi: 10.1002/pro.321.
Bruton's tyrosine kinase (BTK), a member of the TEC family of kinases, plays a crucial role in B-cell maturation and mast cell activation. Although the structures of the unphosphorylated mouse BTK kinase domain and the unphosphorylated and phosphorylated kinase domains of human ITK are known, understanding the kinase selectivity profiles of BTK inhibitors has been hampered by the lack of availability of a high resolution, ligand-bound BTK structure. Here, we report the crystal structures of the human BTK kinase domain bound to either Dasatinib (BMS-354825) at 1.9 A resolution or to 4-amino-5-(4-phenoxyphenyl)-7H-pyrrolospyrimidin- 7-yl-cyclopentane at 1.6 A resolution. This data provides information relevant to the development of small molecule inhibitors targeting BTK and the TEC family of nonreceptor tyrosine kinases. Analysis of the structural differences between the TEC and Src families of kinases near the Trp-Glu-Ile motif in the N-terminal region of the kinase domain suggests a mechanism of regulation of the TEC family members.
布鲁顿酪氨酸激酶(BTK)是 TEC 激酶家族的成员,在 B 细胞成熟和肥大细胞激活中发挥着关键作用。虽然未磷酸化的小鼠 BTK 激酶结构域和未磷酸化及磷酸化的人 ITK 激酶结构域的结构是已知的,但由于缺乏高分辨率的配体结合 BTK 结构,因此理解 BTK 抑制剂的激酶选择性特征一直受到阻碍。在这里,我们报道了与人 BTK 激酶结构域结合的 Dasatinib(BMS-354825)的晶体结构,分辨率为 1.9Å,或与 4-氨基-5-(4-苯氧基苯基)-7H-吡咯并[2,3-d]嘧啶-7-基-环戊烷的晶体结构,分辨率为 1.6Å。该数据为开发针对 BTK 和 TEC 家族非受体酪氨酸激酶的小分子抑制剂提供了相关信息。对激酶结构域 N 端区域中 Trp-Glu-Ile 基序附近 TEC 和 Src 激酶家族之间结构差异的分析表明了 TEC 家族成员的调节机制。